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Objective: To determine the distribution of serogroups/serotypes and antibiotic resistance pattern of Streptococcus 
pneumoniae isolated from pediatric infections in central Greece. 
Methods: In total, 306 S. pneumoniaestrains isolated from children, aged from 18 days to  14years (median 18 months), 
during a 21-month period, from different specimen sources, were studied. Susceptibility testing was carried out by the 
Kirby-Bauer method and by the Etest, and serotyping by the Quellung reaction. 
Results: Of the S. pneumoniae isolates, 3.9% were highly resistant t o  penicillin (PR), while 17.6% were intermediately 
resistant (IPR). PR and IPR isolates were found to  be, in  general, more resistant t o  other antibiotics than penicillin- 
susceptible isolates. The PR and IPR isolates belonged to the serogroup/serotypes 19, 23, 9, 6 and 14 (in descending 
order of frequency). The penicillin-susceptible isolates belonged to 20 different groups/serotypes, the most common 
being 19, 6, 14, 9, 3, 23 and 1 (in descending order of frequency). Serogroup 23 was often found to be multiresistant. 
Conclusions: Resistance to  penicillin in  S. pneumoniae isolates is relatively low and differs according to the specimen 
type. All the pneumococcal serogroups/serotypes isolated from the children were found to be included in the 23-valent 
polysaccharide vaccine. Most of the children with a pneumococcal infection, however, were less than 2 years old and 
could not be protected by the existing vaccine. 
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INTRODUCTION 
Pneumococcal infections exhibit high morbidity and 
mortality rates worldwide. In the USA, for example, 
30% mortality was reported in meningitis cases caused 
by pneumococci, the survivors having a high rate of 
neurologic damage [ 11. Because of this high mortality, 
it is recommended that individuals in a high-risk group 
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should be vaccinated. The risk groups include: the 
elderly (above 65 years), the splenectomized, children 
(especially those in institutions), patients with a history 
of chronic lung, heart, kidney and liver diseases, 
alcoholics, patients with severe diabetes, patients with 
sickle cell anemia, patients with AIDS, and transplanted 
and immunocompromised patients [2]. 
The currently available pneumococcal vaccine 
consists of polysaccharides from the 23 most commonly 
found serogroups/serotypes, covering 90% of the types 
isolated from invasive infections [3-51. Unfortunately, 
the vaccine is not protective in children under 2 years 
old. Protein-conjugated vaccines stimulating the T-cell 
response are under development [2 ,3] .  Epidemiologic 
studies of the serotype distribution and antibiotic 
resistance are necessary in order to know the probable 
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efficacy of a vaccine in a particular area [6] .  In this 
study, the distribution of pneumococcd serogroups/ 
serotypes and antibiotic resistance was determined for 
isolates from pediatric patients in central Greece. 
MATERIALS AND METHODS 
Patients 
Pneumococcal strains were isolated from 306 patients 
from central Greece, aged from 18 days to 14 years 
(median 18 months); 53.6% were under 2 years. The 
study was performed over a period of 21 months 
(October 1995 to June 1997). 
Bacterial strains 
The strains were consecutive isolates and they were 
isolated from different specimen sources: 29 from 
blood/cerebrospinal fluid (CSF), 170 from middle ear 
aspirations, 63 from nasal secretions, 30 from eyes, and 
14 from miscellaneous specimens (five bronchial secre- 
tions, four inflamed appendices, one joint fluid, one 
burn, one neck abscess, one toe abscess, one vulvo- 
vaginitis). Identification of the Streptococcus pneumoniae 
isolates was carried out by colony morphology on 
blood agar. Gram stain, susceptibility to optochin, and 
bile solubility. APIstrep (bioMerieux, France) was used 
where needed. Strains were stored in skimmed milk 
freezing medium and immediately frozen at -7OOC. 
The frozen stains were subcultured in batches and 
inoculated on blood agar for serotyping. 
Antibiotic resistance 
Antibiotic susceptibility testing was performed by the 
Kirby-Bauer method on Mueller-Hinton agar with 5% 
blood, and incubation in the presence of 5% COZ. 
Resistance to penicillin was detected with 1-1-18 
oxacillin disks. The isolates showing a zone diameter 
<20 mm were also tested by Etest (AB Biodisk, Solna, 
Sweden) (according to the manufacturer) to establish 
the MIC of penicillin [7-91. Strains with MIC 
50.06 mg/L were considered to be susceptible (PS), 
those with MIC between 0.1 and 1 mg/L intermediate 
(IPR), and those with MIC 22 .0  mg/L highly resistant 
(PR), according to the NCCLS protocol [lo]. The 
ATCC 49619 S. pneumoniae strain was used as a control 
for the MIC and Grby-Bauer measurements. 
Serotyping 
Serotyping was performed by the Quellung reaction 
with Pneumotest (Statens Serum Institut, Copenhagen, 
Denmark) (61. 
Isolation, identification, serotyping and suscepti- 
bility testing of S. pneumoniae strains were performed 
by a single laboratory (Microbiology Laboratory of ‘P. 
and A. Kyriakou’ Children’s Hospital of Athens). 
In Table 1, the isolation of pneumococci from children 
is presented by the specimen source and disease. Most 
pneumococci were isolated from the middle ears of 
children with acute otitis media (5S.6%). 
Resistance to penicillin in the isolated pneumo- 
coccal strains is shown in Table 2. In total, 3.9% of the 
strains were found to be resistant and 17.6% inter- 
mediately resistant. The antibiotic resistance pattern 
was different in each source. Among the 29 strains 
isolated from blood/CSF cultures, only one was resistant 
and four were intermediately resistant. 
Table 1 The Isolation of S. pneumoniae in children by the source and disease 
Ulood/CSF Middle ear Nose Eyes Miscellaneous Total 
Diceace n 12 tI t1 11 I1 (%I) 
Meningitis/hacterenua 
Hacteremia 
I’neuinonia 
Septic arthritis 
Acute otinc media 
Purulent rhinitis/sinusitis 
Ophthalniia 
Conjunctivitis 
Burn 
Appendicitis/peritonitis 
Toe abscess 
Neck ahscesc 
Vulvovaginitis 
Total 
8 
I 6  
4 
1 
170 
63 
1 
26 
7 
1 
2Y 170 63 30 1 1  
8 (2.6) 
16 (5.2) 
9 (2.9) 
2 (0.6) 
170 (.5.5.6) 
63 (20.6) 
1 (1.3) 
26 (8.5) 
1 (0.3) 
4 (1 3) 
l (O.3)  
1 (0.3) 
1 (0.3) 
306 (100.0) 
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Sixty-six P R  and IPR strains were serotyped (Table 
3). These were found to belong to serogroups/ 
serotypes 19, 23, 9, 6 and 14, in descending order of 
frequency. Fortythree of the 66 children (65.1%) from 
Table 2 Resistance to penicillin of 306 S. pneumoniae 
isolates by the specimen source 
Intermediate Resistant Total 
Source of isolation n (“h) n (%) n (%) 
Blood/CSF (n=29) 4 (13.8) 1 (3.4) 5 (17.2) 
Middle ear (n=170) 35 (20.6) 7 (4.1) 42 (24.7) 
Nose (n=63) 8 (12.7) 2 (3.1) 10 (15.9) 
Eyes (n=30) 6 (20.0) 1 (3.3) 7 (23.3) 
Miscellaneous (n=14) 1 (7.1) 1 (7.1) 2 (14.3) 
Total (n=306) 54 (17.6) 12 (3.9) 66 (21.5) 
whom the pneumococci were isolated were under the 
age of 2 years. Serotyping of all the 240 PS pneu- 
mococcal strains, according to the specimen source, is 
presented in Table 4. Twenty different serotyped 
serogroups were detected, the most frequent being 
serogroup 19 (23.7%), followed by 6, 14, 9, 3, 23 and 
1, in descending order. The resistance to antibiotics of 
306 S. pneumoniae  isolates is shown in Table 5, 
separately for PR,  IPR and PS strains. The resistance 
patterns and serogroups/serotypes of the antibiotic- 
resistant s. pneumoniae isolates are shown in Table 6. 
DISCUSSION 
The total resistance of pneumococci to penicillin 
(which has been reported to be the antibiotic of first 
Table 3 Serotyping of PR and IPR S. pneumoniae isolates by the specimen source 
Blood/CSF Middle ear Nose Eyes Miscellaneous 
Serogroup/ IPR PR IPR P R  IPR PR IPR P R  IPR PR Total 
serotype n n n n n n n n n n n (“A) 
19 15 5 3 3 1 1 28 (42.4) 
23 2 1 10 2 3 2 2 1 23 (34.8) 
9 1 8 1 10 (15.1) 
14 1 1 2 (3.0) 
Total 4 1 35 7 8 2 6 1 1 1 66 (100.0) 
6 1 1 1 3 (4.5) 
Table 4 Serotyping of 240 PS S. pneumoniae isolates by the specimen source 
Serogroupl Blood/CSF Middle ear Nose Eyes Miscellaneous Total 
srrotype n n n n n n (“A) 
19 
6 
14 
9 
3 
23 
1 
12 
18 
15 
17 
11 
8 
7 
4 
20 
10 
22 
33 
3 
2 
1 
1 
1 
31 
15 
17 
12 
15 
6 
5 
6 
3 
2 
3 
1 
4 
1 
3 
1 
1 
1 
1 
1 
2 
1 
1 
2 
2 
1 
2 
2 
1 
3 
1 
1 
1 
2 
1 
57 (23.7) 
36 (15.0) 
27 (11.2) 
25 (10.4) 
20 (8.3) 
13 (5.4) 
10 (4.2) 
8 (3.3) 
7 (2.9) 
6 (2.5) 
5 (2.1) 
5 (2.1) 
5 (2.1) 
3 (1.2) 
3 (1.2) 
2 (0.8) 
1 (0.4) 
4 (1.7) 
2 (0.8) 
1 (0.4) 
Total 24 128 53 23 12 240 (100.0) 
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Table 5 Resistance to other antibiotics of PK, IPR and PS 
S. pncumoniar strains 
I’R IPK PS 
(n=12) ( 1 1  = .54) (n=240) 
Antibiotic t1 tI 11 
Oxacillin 12 54 3 
Erythromycin 6 8 10 
3 Clindaniycin - 3 4 
l<ifanipicin 0 0 2 
Triniethoprini/ 
wlfaniethoxazole 8 29 13 
CeLiclor 9 8 0 
C eio taxi m e 0 1 0 
7 C:liloi-aniphenicol - 11 3 
Tetracycline 6 23 7 
Vancomycin 0 0 0 
choice) seems to be relatively low, with 3.9% being 
highly resistant and 17.6%) intermediate. These 
percentages vary according to the source of isolation. 
The highest frequency of PR and IPR strains was 
found in the middle ear aspirates from children with 
acute otitis media, followed by isolates from eye 
secretions from children with conjunctivitis and 
ophthalmia. To a lesser extent, resistant strains were 
isolated from nasal swabs and from blood/CSF cultures 
from children with bacteremia or meningitis. 
In previous studies from a Greek hospital treating 
adult patients with respiratory tract infections, 13% of 
the isolates were resistant to oxacillin 1111. Among 
isolates from nasopharyngeal swabs from children 
Table 6 Kcsistance patterns and serogroup/serotype of antibiotic-resistant S. pweumoniae isolates froin clinical specimens in 
children 
Serogroup/Serorype 
Kewtance pattern tI (9%) 19 23 9 6 14 15 4 
Pel1 
Em 
Te t 
TMP-SMZ 
KMI’ 
Peii/Tet 
Pen/TMP-SMZ 
I’cn/C;hl 
Eiii/Chl 
EiidTMP-SMZ 
Tet/TMP-SMZ 
I’en/Tet/TMP-SMZ 
I’en/Chl/Cfac 
Pen/Ern/Cfac 
Peii/Cfac/TMP-SMZ 
Pen/Chl/TMP-SMZ 
Eni/Cni/KMP 
Pen/Em/Cfac/TMP-SMZ 
Pen/(:iii/(:fac/TMP-SMZ 
Peii/Tet/Cfac/TMP~SMZ 
Peii/Cfac/Chl/TMP-SMZ 
Eiii/Ciii/Tet/TMI’-SMZ 
Pcn/Em/Trt/Cfac/TMP-SMZ 
Pen/Chl/Cfac/TMP-SMZ/Trt 
Prii/Eni/Tet/TMP-SMZ/(:m 
Pen/Eni/Cin/Chl/Tet 
Chl/Eni/Tet/TMP-SMZ/Ciii 
Em/C:m/TMP’-SMZ/Chl/Tet 
Pen/Tet/Cfac/CTX/ChI/TMP-SMZ 
I’cn/Tct/Ern/Cni/Clil/TMP-SMZ/C~ac 
18 (5.9) 
4 (1.3) 
1 (0.3) 
7 (2.3) 
1 (0.3) 
7 (2.3) 
6 (2.0) 
1 (0.3) 
I (0.3) 
1 (0.3) 
l(O.3) 
1 (0.3) 
6 (2.0) 
1 (0.3) 
l(0.3) 
2 (0.6) 
1 (0.3) 
3 (1.0) 
1 (0.3) 
1 (0.3) 
4(1.3)  
5 (1.6) 
4 (1.3) 
1 (0.3) 
1 (0.3) 
1 (0.3) 
1 (0.3) 
1 (0.3) 
2 (0.6) 
2 (0.6) 
14 
1 
- 3
4 
1 
1 
1 
1 
1 
1 
1 
‘l 
2 - 7
1 
1 Z 
2 
1 - 7 - 3
1 
1 
1 
1 
1 
2 
1 
h 
1 
I 
1 
2 
1 
Total 87 (28.4) 32 26 1 1  10 6 I 1 
Pen, penicillin; Em, erythromycin; Tet, tetracycline; TMP-SMZ. trirnethoprim/~ulfamethoxazole: RMI! rlhmpicin: Chl, chloraniphenicol: 
Chc, cefaclor; CTX, cefotaxinir; Cm, clindamycin. 
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attending day-care centers in south-west Greece, 12% 
were P R  and 17% IPR [12]. 
Worldwide, the highest antibiotic resistance to 
penicillin is reported to be in South Africa, Spain, 
eastern Europe and Korea [13]. In Europe, Hungary 
and Spain have the highest isolation rates of P R  
pneumococci [14]. Our  present study shows that in 
central Greece the percentage of resistant strains is 
higher than in the Scandinavian countries, The 
Netherlands or Germany, where a relatively restrictive 
antibiotic policy is practised [14]. 
The P R  and IPR isolates belonged to the sero- 
groups/serotypes 19, 23, 9, 6 and 14. The same 
serogroups/serotypes are among the most common 
resistant strains elsewhere in Europe and in the USA 
[ 14-1 71. The only differences among the reports are in 
the relative frequencies with which these five sub- 
groups/serotypes are represented. In this study, we 
showed that all the pneumococcal serogroups/serotypes 
isolated from children are included in the clinically 
available 23-valent polysaccharide vaccine. However, 
53.6% of those children were under 2 years, and 
therefore cannot be protected by the vaccine. 
One isolate was resistant to third-generation 
cephalosporins (0.3%). The resistance to erythromycin, 
chloramphenicol and other antibiotics was relatively 
low. Antibiotic resistance differs from country to 
country, being especially high in a report from Atlanta, 
USA: 26% resistant to co-trinioxazole, 15% to 
erythromycin, and 9% to cefotaxime, and 7% PR and 
18% IPR [18]. In Belgium the resistance to erythro- 
mycin was reported to be 21.5% [17], and in Spain the 
resistance to cefotaxime 9% and to chloramphenicol 
43% [19]. In general, it is reported that the PR and 
IPR strains are often also resistant to other antibiotics 
except vancomycin [13], and this is also confirmed by 
the present study. 
In our study the antibiotic pattern showed 30 
different types, with resistance to one to seven anti- 
biotics. Multiresistance (resistance to three or more 
distinct classes of antibiotics) was most common in 
strains of serogroup 23, followed by 19, 9, 6 and 14. 
Multiresistance associated with serogroup 23 has been 
reported in other European countries and in other parts 
of the world [20-221. 
In conclusion, the resistance to penicillin of 
pneumococci isolated from pediatric infections in 
central Greece is relatively low (3.9% PR and 17.6% 
IPR) and differs according to the specimen source. Our 
findings suggest that it is necessary to keep under 
review the antibiotic policy for the empirical treatment 
of various infections in Greece. 
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